"","Cites","Authors","Title","Year","Source","Publisher","ArticleURL","CitesURL","GSRank","QueryDate","Type","DOI","ISSN","CitationURL","Volume","Issue","StartPage","EndPage","ECC","CitesPerYear","CitesPerAuthor","AuthorCount","Age","Abstract","generic_drug_name"
"1",0,"T.M. Estes","Dual spinal cord injury: a case of acute traumatic T9 AIS A spinal cord injury complicated by transverse myelitis",2020,"Spinal Cord Series and Cases",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089776133&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85089776133&origin=inward",4,"2021-01-16 11:49:45","Article","10.1038/s41394-020-00329-7","2058-6124","https://api.elsevier.com/content/abstract/scopus_id/85089776133",6,1,NA,NA,0,0,0,1,1,NA,"ceftriaxone"
"2",4,"J. Tajkey","Comparative study on the effects of ceftriaxone and monocytes on recovery after spinal cord injury in rat",2015,"Advanced Pharmaceutical Bulletin",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84930395276&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84930395276&origin=inward",3,"2021-01-16 11:49:45","Article","10.15171/apb.2015.026","2228-5881","https://api.elsevier.com/content/abstract/scopus_id/84930395276",5,2,189,194,4,0.67,4,1,6,NA,"ceftriaxone"
"3",6,"M. Rathore","Acute flaccid paraplegia: A rare complication of meningococcal meningitis",2008,"Spinal Cord",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=41849123872&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=41849123872&origin=inward",2,"2021-01-16 11:49:45","Article","10.1038/sj.sc.3102120","1362-4393","https://api.elsevier.com/content/abstract/scopus_id/41849123872",46,4,314,316,6,0.46,6,1,13,NA,"ceftriaxone"
"4",67,"A. Rabchevsky","Pharmacological interventions for spinal cord injury: Where do we stand? How might we step forward?",2011,"Pharmacology and Therapeutics",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79960570561&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=79960570561&origin=inward",1,"2021-01-16 11:49:45","Review","10.1016/j.pharmthera.2011.05.001","0163-7258","https://api.elsevier.com/content/abstract/scopus_id/79960570561",132,1,15,29,67,6.7,67,1,10,NA,"ceftriaxone"
